$8.6 MILLION MORE 💜 That’s how much we increased our new pancreatic cancer research funding in FY26! Together, we invested in bold ideas. This coming year, we’re expanding that investment & we need your support to keep the momentum going. See where this investment is going: lfdn.org/4bTbe4j

What is clinical research and why does it matter? 💜 It’s where discovery meets patient care, turning promising ideas into evidence through clinical trials. At Lustgarten, we’re working to make pancreatic cancer trials smarter, faster & more accessible. 🔗 lfdn.org/4gBqxBc

On National Nonprofit Day, we’re celebrating the community powering progress. 💜 As funding cuts threaten scientific momentum, your support helps Lustgarten double down on the research patients need. Led by Lustgarten. Powered by you. See what we accomplished together: lfdn.org/4bTbe4j

Where do pancreatic cancer breakthroughs begin? 💜 Join our next LustgartenLIVE! to hear three leading investigators share surprising new insights into how dietary fats, molecular pathways and the nervous system may shape the disease. Save your spot: lfdn.org/Innovation-L...

3 more chances to take the plunge for pancreatic cancer research! 💜 Dunk for a Cure is heading to Cincinnati (8/15), Richmond (8/29) and Denver (9/27) as Fight Cancer Stay Positive (FCSP) nears $1M raised in support of research through the Lustgarten Foundation. Sign up today: lfdn.org/dunk

A new clinical trial is bringing a promising approach to pancreatic cancer treatment one step closer to patients. 💜🧵👇

Today is Lustgarten Giving Day! 💜 And for the next 24 hours, your gift will go TWICE AS FAR.

What if researchers could study a patient’s tumor without relying on the same traditional cancer models used for decades? 🧵👇

🎉 Congratulations to Rebecca Snyder, MD, and Heather G. Lyu, MD, MBI, @mdanderson.bsky.social, on receiving Lustgarten's 2026 LEAD Project grant! Their team's AI-powered project will make clinical trial matching easier for pancreatic cancer patients. 💜 Tell me more: lfdn.org/2026-LEAD

Lustgarten's Giving Day is almost here! 💜 Join us (in less than 2 weeks!) as we celebrate our 28th anniversary with 24-hours of matched giving 👉 DOUBLE YOUR IMPACT! Last year you helped raise more than $40,000, fueling cutting-edge research. This year we’re aiming even higher. 🗓️ bit.ly/3TjknfY

Former senator Ben Sasse discussed his experience living with pancreatic cancer & the investigational therapy daraxonrasib, sharing that his tumors have shrunk by 80%. The drug is a major milestone underscoring the impact of sustained funding of bold, collaborative research. lfdn.org/daraxonrasib

The FDA has accepted for review Revolution Medicines' New Drug Application (NDA) for daraxonrasib, an important regulatory milestone following the landmark Phase 3 RASolute 302 trial. While not an approval, it moves this treatment one step closer to patients. 💜 Tell me more: lfdn.org/daraxonrasib

Behind every breakthrough is the infrastructure that makes discovery possible! Thanks to the Cinelli Family Foundation's $350K grant, LUCID will help researchers connect clinical trial data across institutions, accelerating discovery & improving future pancreatic cancer research: lfdn.org/4fLfVzk 💜

Could we prevent pancreatic cancer before it starts? 💜 An early clinical trial showed a KRAS-targeting vaccine was safe and generated an immune response in 90% of high-risk participants. Tell me more: lfdn.org/vaccine-prev...

Four new grants. Four bold approaches to advancing pancreatic cancer care. 💜 The 2026 Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative recipients will lead smarter, science-driven trials focused on targeted treatment, immunotherapy, biomarkers & cancer interception: lfdn.org/4yq8Co1

What a day, Naperville! 💜 Because of this community, more than $85K was raised to support pancreatic cancer research this year alone! We’re grateful to every participant, team, volunteer, donor, and sponsor who helped bring the event to life.

Pancreatic cancer cells are built to survive. New Lustgarten-funded research from @salkinstitute.bsky.social scientists explores how entinostat may help weaken that defense and make cancer cells more vulnerable to treatment: bit.ly/4v7wud4

This Independence Day, as America marks 250 years, we’re reminded that progress has always depended on people who believe a better future is possible. Today and every day, that belief drives our work for everyone facing pancreatic cancer. 💜

“There's no way I’m going to leave my little girl yet.” 💜 Kerri Page lost her mother to pancreatic cancer. Over 20 years later, she faced the same diagnosis. Her story captures a reality many survivors know well: receiving clean scans while still carrying fear, uncertainty, and hope for more time.

Breakthroughs take time, trust, and independent science. Proposed changes to federal grantmaking could weaken peer review and threaten the research system pancreatic cancer patients depend on. Call your representatives and urge them to protect federal research funding: congress.gov.

What's next for KRAS-targeted therapies? We're investing $16M with @break-cancer.bsky.social & the Cinelli Family Foundation to unite six leading institutions to find out! 💜 Read the FULL release: lfdn.org/KRAS_2

Two researchers. Two bold approaches. One shared goal: moving pancreatic cancer research forward. 💜 Congratulations to Sandra Misale, PhD, and Dig B. Mahat, PhD, our 2026 Lustgarten Foundation-AACR Career Development Award recipients. Get more details: lfdn.org/4anWYzI

Behind every dunk is something bigger: research, progress, and hope for patients and families facing pancreatic cancer. 💜 Through Dunk for a Cure events across the country, the FCSP Foundation brings communities together for a fun, meaningful way to support those facing pancreatic cancer.

Brittany Vose was just 5 years old when she lost her father, John, to pancreatic cancer. At 13, she organized her first walk in a small parking lot near her home. What started as a simple act of remembrance has grown into the 18 Hole Stroll, raising more than $1M for pancreatic cancer research.

Progress in pancreatic cancer does not happen by chance. It happens through years of research, collaboration, and the belief that even the toughest scientific barriers can be broken.

Every step in Westchester carried something bigger: remembrance, resilience, hope, and a shared commitment to progress. 💜

The future of pancreatic cancer care is being shaped by a community that is inspiring hope and refusing to accept the status quo. 💜🧵👇

Six years after her pancreatic cancer diagnosis, Sharon Bond is sharing her story to help inspire hope for others. 💜 (1/4)

It’s a question the pancreatic cancer community is asking, and one our experts will help unpack. 🙌

From Milford (CT) to Tampa (FL) to Monmouth (NJ), our Walks brought together an incredible community united by one mission: changing the future of pancreatic cancer. 💜